Where Is the Pituitary Gland Located: Sella Turcica Anatomy and Clinical Depth

The pituitary gland is located in the sella turcica, a bony depression on the upper surface of the sphenoid bone at the skull base, roughly 6–9 cm behind the bridge of the nose and directly below the brain's hypothalamus. It sits in the midline, behind the nasal cavity and sphenoid sinus, and above it lies the diaphragma sellae, a dural sheet pierced by the pituitary stalk.

That location looks simple on a diagram. It is not simple in surgery, in imaging, or in the endocrine clinic. The gland is packed against the optic chiasm, wrapped near the cavernous sinuses and internal carotid arteries, and connected upward to the hypothalamus by a stalk only millimeters long. Those neighbors explain most of the symptoms that reveal a pituitary problem, and they explain why "where is the pituitary gland located" is a more clinically loaded question than it first appears.

Sella turcica anatomy: the bony saddle beneath the brain

The sphenoid bone contributes the sella turcica, Latin for "Turkish saddle." Its floor is the sphenoid sinus roof; its front wall carries the tuberculum sellae; its back wall is the dorsum sellae. The pituitary sits inside this cup like a pea in a shallow bowl. In adults the sella measures roughly 10–15 mm in anteroposterior diameter, 10–15 mm in width, and 5–7 mm in height. These dimensions matter because adenomas are staged partly by how far they exceed them.

The gland itself is small and bipartite. The anterior pituitary, or adenohypophysis, makes up roughly 80% of the volume and derives from upward-migrating Rathke pouch ectoderm. The posterior pituitary, or neurohypophysis, is neural tissue and stores hormones shipped down from hypothalamic neurons. In adults the whole gland weighs about 0.5–0.6 g and measures roughly 8 mm vertically, 12 mm transversely, and 6 mm anteroposteriorly. It is larger in pregnancy and adolescence, when physiologic hypertrophy can push its height toward 10–12 mm.

The location creates a mechanical constraint. Because the sella is rigid bone with only a small dural opening above, any expanding mass compresses upward rather than outward. That single fact explains the classic bitemporal visual field defect and the headache pattern of pituitary disease. Plainly: the gland lives in a closed bony cup with a narrow lid.

How the stalk and cavernous sinuses shape pituitary function

The pituitary stalk, or infundibulum, is a funnel of tissue 3–5 mm long connecting the hypothalamus to the gland. It carries two opposite flows. Hypothalamic releasing and inhibiting hormones travel down portal capillaries to the anterior lobe. Neurohypophyseal axons carry vasopressin and oxytocin down to the posterior lobe for storage. A lesion that compresses or severs the stalk disconnects these flows, and the result is not simple hormone deficiency but predictable stalk-effect physiology.

Laterally, the cavernous sinuses flank the sella on both sides. Each contains the internal carotid artery and cranial nerves III, IV, V1, V2, and VI. The pituitary is separated from this crowded corridor by a thin dural wall. An adenoma that invades laterally can produce double vision or facial numbness before it produces endocrine symptoms. The optic chiasm sits above and slightly anterior, usually about 5–10 mm above the diaphragma sellae. Upward growth of only a few millimeters brings a tumor into contact with the crossing nasal fibers that serve both temporal fields.

Blood supply reinforces the location's significance. The anterior lobe receives most of its blood through the hypophyseal portal system, not the systemic circulation. That portal route is why hypothalamic signals reach the gland at high concentration, and why stalk compression can paradoxically raise prolactin: dopamine, the inhibitory signal, no longer arrives. This is the counterintuitive detail worth remembering. A mass pressing on the stalk typically causes hyperprolactinemia with hypogonadism, not low prolactin.

Quantified context: size, imaging, and the numbers that matter

Normal pituitary height is not one number. In men it averages about 6 mm. In nonpregnant women it averages about 7 mm and can reach 9 mm. Pregnancy drives normal physiologic expansion to 10–12 mm by the third trimester. Puberty shows a transient growth spurt in gland height. After menopause, height tends to decline slightly as the gland becomes more heterogeneous on MRI.

Sellar size varies too. Standard adult sella dimensions of roughly 10–15 mm in each horizontal axis mean that macroadenomas, defined as lesions 10 mm or larger, already occupy most of the available space. Microadenomas, under 10 mm, often sit entirely within the sella and are frequently incidental. An empty sella, where cerebrospinal fluid fills part of the sella and flattens the gland against its floor, is a common benign variant seen in up to roughly 5–35% of imaging series depending on criteria.

Imaging protocols are built around the location. Dedicated pituitary MRI uses thin slices, typically 2–3 mm, in coronal and sagittal planes with dynamic contrast timing. Computed tomography is faster but exposes the region to radiation and resolves soft tissue poorly. The skull-base position also means transsphenoidal surgery, the standard approach for most pituitary tumors, enters through the nostril and sphenoid sinus rather than through the cranium. That route shortens the distance to the gland to a few centimeters and avoids brain retraction entirely.

Edge cases: when the pituitary is not where expected

Rare ectopic locations exist. Ectopic posterior pituitary tissue can appear along the stalk or at the median eminence in congenital pituitary disorders, and it is associated with childhood growth hormone deficiency and other hormone deficits. Rathke cleft cysts, remnants of the embryologic Rathke pouch, arise within or adjacent to the sella and can mimic adenomas. Craniopharyngiomas typically arise above the sella in the suprasellar region and often calcify.

The empty sella deserves attention because it contradicts the intuition that a visible gland must fill its bony home. In this variant, a defect in the diaphragma sellae lets cerebrospinal fluid enter, flattening the pituitary against the sellar floor. Most people with an empty sella have normal hormone function, though some develop deficits. This is a professional caveat worth stating plainly: a normal-sized gland is not always a healthy one, and a small or flattened gland is not automatically failing.

Infection and inflammation can also center on this site. Lymphocytic hypophysitis, an autoimmune inflammation of the gland, produces enlargement that mimics a tumor. Pituitary apoplexy, sudden hemorrhage or infarction within an adenoma, is a medical emergency with abrupt headache, visual loss, and hormone collapse. Pregnancy magnifies the stakes because normal gland enlargement can mask or mimic adenoma growth, and postpartum infarction of an enlarged gland, Sheehan syndrome, can cause lasting deficiency.

Misconceptions: what the location does and does not explain

The most common misconception is that the pituitary is the "master gland" in a way that makes it self-directing. It is not. The hypothalamus sits directly above it and drives its output through releasing and inhibiting hormones. The pituitary is better described as a relay station and amplifier than as an autonomous controller. That hierarchy matters when interpreting lab results: low pituitary output can reflect hypothalamic failure, stalk interruption, or end-organ feedback, and the pattern of multiple hormone deficits usually distinguishes them.

A second misconception is that the gland sits inside the brain. It does not. The pituitary lies below the brain, outside the blood-brain barrier in part, housed in the skull base within the sella. That extracerebral position is why the transsphenoidal route works and why the gland can be reached without opening the cranial vault. It also explains why some pituitary conditions present with sinus or nasal symptoms rather than classic neurologic ones.

A third is that symptoms map neatly to anatomy. A microadenoma may cause hormone excess with no mass effect at all. A macroadenoma may produce visual loss before any endocrine abnormality. A lesion compressing the stalk can raise prolactin while lowering other hormones. The location supplies the risk map; it does not supply a single symptom signature.

Sudden severe headache with visual loss or double vision: consider pituitary apoplexy and seek emergency care. New bitemporal visual field loss: urgent pituitary imaging and visual field testing are warranted. Excessive thirst and urination with headache or visual changes: evaluate for diabetes insipidus and mass effect. Unexplained galactorrhea or hypogonadism with a sellar mass: assess for stalk effect rather than assuming prolactinoma. Visual symptoms during pregnancy in a person with known pituitary disease: urgent specialist review, because normal enlargement can compress the chiasm. Postpartum failure to lactate with fatigue and amenorrhea: evaluate for Sheehan syndrome.

Practical actions: how to reason about the location clinically

For a person with a suspected pituitary issue, the practical sequence starts with localization. A dedicated pituitary MRI with thin coronal and sagittal slices is the imaging standard; noncontrast CT is a poor substitute for soft-tissue detail near the sella. Visual field testing, especially automated perimetry, complements imaging when a mass approaches the chiasm. Baseline endocrine testing should cover prolactin, morning cortisol, free thyroxine, and gonadal hormones, with growth hormone and vasopressin testing added when the clinical picture warrants it.

Thresholds require explicit reconciliation. A lesion of 10 mm separates microadenoma from macroadenoma by convention, but size alone does not dictate intervention. Prolactin elevation above roughly 200 ng/mL strongly suggests a prolactinoma rather than stalk effect, though the exact cutoffs vary by assay and laboratory. Pituitary height above about 8–9 mm in a nonpregnant adult is generally reported as enlarged, but pregnancy and puberty shift that threshold legitimately. These numbers are decision aids, not verdicts, and they should be interpreted against symptoms, age, and hormonal context rather than in isolation.

For clinicians planning intervention, location dictates approach. Most pituitary tumors are reached transsphenoidally through the sphenoid sinus. Suprasellar extension may require extended approaches. Lateral invasion into the cavernous sinus limits complete resection because of carotid and cranial nerve risk. Radiation therapy is reserved for residual or recurrent disease and is planned around the gland's proximity to the optic apparatus. Each of these choices flows from the 1–2 cm of anatomy that separates the gland from its neighbors.

Limitations and what the location cannot tell you

Anatomy answers where the gland is. It does not answer what is wrong with it. Imaging findings near the sella frequently lack specificity: an enlarged gland may be adenoma, hyperplasia, hypophysitis, or physiologic change. A normal-sized gland may be dysfunctional. Stalk compression can produce a hormonal pattern that mimics a secreting tumor. The location narrows the differential; it never closes it.

Functional testing and, in some cases, tissue diagnosis remain necessary. This article describes anatomy and physiology at a general level. It is not a diagnosis, a treatment plan, or a substitute for specialist evaluation. Anyone with visual loss, severe sudden headache, or suspected pituitary hormone deficiency should be assessed promptly by a qualified clinician, and emergencies should go to local emergency services.